Last year, according to the World Economic Forum, 77,000 new ventilators were enough to meet the market demand worldwide. For context, this month …
Little known biotech Aim ImmunoTech (AIM) has soared by a massive 382% year-to-date. Yet, Maxim’s analyst Jason McCarthy argues the $75 million market …
After weeks of historic uncertainty, global stock markets are quickly settling down from now what is now nearly a month of record share …
The battle against COVID-19 is well underway, and now’s the time to send in the big guns. Sorrento Therapeutics (SRNE) is on it, …
Amid the ongoing public health crisis, Wall Street is eagerly awaiting any piece of good news. Inovio Pharmaceuticals (INO) just came through.
With the war against COVID-19 waging on, Wall Street focus has locked in on the names at the frontline. Battling a formidable opponent …
In times of high volatility, precious metals would see increased purchases as investors seek a safe haven. Gold, the original hard cash, is …
We’ve had more good news in the stock markets this week, lending credence to the view that recent gains are more than just …
Is now the right time to unleash a new product? Whether it is or not, according to one analyst, Apple (AAPL) is readying …
Is anything going to stop Amazon’s (AMZN) march towards world domination? It certainly won’t be COVID-19.
